| answer text |
<p>The human papillomavirus (HPV) vaccination, alongside routine screening, is key
to protecting people against strains of HPV that can cause some cancers including
cervical, anal, head and neck cancer.</p><p>The NHS Cervical Screening Programme (CSP)
provides all women and people with a cervix between the ages of 25 and 64 years old
with the opportunity to be screened routinely, to detect certain types of HPV infection
which cause 99.7% of cervical cancer. An in-service evaluation is being commissioned
by the National Institute for Health and Care Research to determine whether HPV self-sampling
could be used to improve the NHS CSP.</p><p>The HPV vaccination is offered to all
adolescents in Year 8 of school, and catch-up vaccinations are available to those
up to 25 years old, those born on or after 1 September 2006, for both females and
males who may have missed vaccination under the schools’ programme, providing an additional
failsafe. The HPV vaccination is also recommended to gay, bisexual, and other men
who have sex with men, up to and including those aged 45 years old.</p><p>NHS England’s
vaccination strategy sets out a range of ambitions to improve uptake across the National
Health Service’s vaccination programmes. This includes building on existing work and
delivery to develop implementation plans for how HPV vaccinations, alongside cervical
screening and pre-cancer treatment, can help achieve the NHS ambition to eliminate
cervical cancer by 2040.</p>
|
|
